Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Mark Horowitz
Redressing long-term antidepressant use (RELEASE): Pragmatic cluster randomised controlled trial in general practice
Katharine Wallis declares receiving reimbursement of travel expenses to attend the European College of Neuropsychopharmacology congress 2025. Joanna Moncrieff declares grants from the National Institute for Health Research, Royalties for books about psychiatric drugs, and being co-chairperson of the Critical Psychiatry Network.
Semiconductors
. Artificial Intelligence . Biotechnology and Synthetic Biology . Cryptography and Computer Security . Energy Technologies . Materials Science . Neuroscience . Quantum Technologies . Robotics .
Is Your APA Strategy Ready for the IRS’s Acceptance Standards?
With the IRS’s acceptance process for advance pricing agreements, or APAs, now incorporated in the Internal Revenue Manual and thus firmly entrenched in administrative guidance and policy, taxpayers contemplating an APA in 2026 face a more rigorous—though clearer—pre-filing landscape. That doesn’t mean the demise of APAs. The program remains robust, and the majority of potential APAs shouldn’t face any serious impediment.
Is Your APA Strategy Ready for the IRS’s Acceptance Standards?
With the IRS’s acceptance process for advance pricing agreements, or APAs, now incorporated in the Internal Revenue Manual and thus firmly entrenched in administrative guidance and policy, taxpayers contemplating an APA in 2026 face a more rigorous—though clearer—pre-filing landscape. That doesn’t mean the demise of APAs. The program remains robust, and the majority of potential APAs shouldn’t face any serious impediment.
Rearranging Deck Chairs While the Titanic Goes Down—The American Society of Clinical Psychopharmacology Issues Deprescribing Recommendations
In February, the American Society of Clinical Psychopharmacology (ASCP) issued a series of recommendations on psychotropic drug deprescribing.1 Derived from a Delphi survey completed by a 45-member international task force, the recommendations purport to offer guidance to clinicians on when and how psychiatric drugs should be deprescribed. Consensus was deemed to have been achieved if 75% of respondents endorsed a recommendation, and the task force reached agreement on 44 of 50 Delphi statements.
Deconstruction of a spino-brain–spinal cord circuit that drives chronic pain
Abstract Tissue inflammation or nerve injury at the periphery can cause chronic pain. Although the spinal-cord-projecting neurons in the rostral ventromedial medulla (RVMSC neurons) can promote pain chronification1,2,3,4, the pathway by which peripheral injury signals drive these neurons is poorly understood1,2,3,5.
Supporting General Practitioners to Deprescribe Benzodiazepines and Z‐Drugs in Primary Care: Findings From a Modified Delphi Study
1 Background For over 40 years, there have been calls for increased vigilance in the prescribing of benzodiazepines, and more recently, Z-drugs—collectively known as benzodiazepine receptor agonists (BZRAs) [1]. BZRAs are commonly prescribed to manage insomnia and anxiety; however, guidelines internationally recommend they should not be prescribed for longer than 4 weeks due to a range of adverse effects, including the risk of dependence and withdrawal on stopping or reducing [2-4].
Supporting General Practitioners to Deprescribe Benzodiazepines and Z‐Drugs in Primary Care: Findings From a Modified Delphi Study
Conflicts of Interest EO works at Reconnexion, a state-funded service in Victoria, Australia, providing specialist treatment for benzodiazepine withdrawal. This study was undertaken as part of the Benzo PACED project, with funding from the Victorian Government via the Alcohol and Drug Research Innovation Agenda (ADRIA) provided by the Victorian Alcohol and Drug Association (VAADA) (Grant ID: #101). MP and KG report that financial support was provided by this grant.
Interpretation of the HAMLETT Study
To the Editor We congratulate Sommer and colleagues1 on completing the Handling Antipsychotic Medication Long-Term Evaluation of Targeted Treatment (HAMLETT) randomized clinical trial, a large and ambitious study addressing the crucial question of whether antipsychotic medication can be safely reduced or discontinued after remission from a first psychotic episode. Their contribution adds valuable data to the field.
Helping people to discontinue antipsychotics: if, when and how - Schizophrenia
Abstract The default position in the treatment of psychotic conditions is that lifelong treatment is required after multiple episodes, with some portion of patients able to stop after a single episode.
Scientists warn antidepressant withdrawal downplayed by ‘industry-funded’ studies
Microsoft Cares About Your Privacy Microsoft and our third-party vendors use cookies to store and access information such as unique IDs to deliver, maintain and improve our services and ads. If you agree, MSN and Microsoft Bing will personalise the content and ads that you see. You can select ‘I Accept’ to consent to these uses or click on ‘Manage preferences’ to review your options and exercise your right to object to Legitimate Interest where used.
Scientists warn antidepressant withdrawal downplayed by ‘industry-funded’ studies
A new review of antidepressant withdrawal effects – written by academics, many of whom have close ties to drug manufacturers – risks underestimating the potential harms to long-term antidepressant users by focusing on short-term, industry-funded studies. There is growing recognition that stopping antidepressants – especially after long-term use – can cause severe and sometimes debilitating withdrawal symptoms, and it is now acknowledged by the UK government as a public health issue.
Scientists warn antidepressant withdrawal downplayed by ‘industry-funded’ studies
A new review of antidepressant withdrawal effects – written by academics, many of whom have close ties to drug manufacturers – risks underestimating the potential harms to long-term antidepressant users by focusing on short-term, industry-funded studies. There is growing recognition that stopping antidepressants – especially after long-term use – can cause severe and sometimes debilitating withdrawal symptoms, and it is now acknowledged by the UK government as a public health issue.
Scientists warn antidepressant withdrawal symptoms are being downplayed
A new review of antidepressant withdrawal effects – written by academics, many of whom have close ties to drug manufacturers – risks underestimating the potential harms to long-term antidepressant users by focusing on short-term, industry-funded studies. There is growing recognition that stopping antidepressants – especially after long-term use – can cause severe and sometimes debilitating withdrawal symptoms, and it is now acknowledged by the UK government as a public health issue.
Meet Students Where They Are? Maybe Not.
A moral injunction popular in today’s academy is to “meet students where they are.” The idea appears unimpeachable. If educators encounter students incapable of meeting the course expectations of prior years (exacerbated, perhaps, by pandemic learning loss), what sense does it make to teach over their heads? Aren’t we responsible for ensuring that all students at least learn something, even if that means adjusting our expectations?
Opinion | Meet Students Where They Are? Maybe Not.
6 hours ago Over the course of several months, Pauline Shanks Kaurin concluded she no longer had the academic freedom necessary for doing her job. Seven years ago, Pauline Shanks Kaurin left a good job as a tenured professor at a university, uprooted her family, and moved across the country to teach military …
Evidence for ApoE receptor 2-Disabled homolog-1 pathway disruption in the amygdala in sporadic Alzheimer's disease
The National Institutes of Health filed a patent application related to mechanism-based biomarkers that are broadly related to this manuscript, with one coauthor (CR) named as an inventor. This project was supported by the intramural programs of NIA (1ZIAAG000453), NIAAA and NINDS, NIH. Additional support was provided as a research gift from John M. Davis to the Laboratory of Clinical Investigation, NIA/NIH.
The Blogs: Peter Beinart's bewildering path
I know it’s wrong, but I’m starting to feel bad for Peter Beinart. Sure, he’s a columnist at the New York Times, a tenured professor at CUNY, and he has a best-selling new book out called Being Jewish After the Destruction of Gaza: A Reckoning.
How to Stop a Psychiatric Med
Home » How to Stop a Psychiatric Med Expert Q&A Mark Horowitz, MBBS, PhD Research and Development Department, Goodmayes Hospital, North East London NHS Foundation Trust, Essex, UK; Visiting Lecturer in Psychopharmcology, King’s College London. Co-author of The Maudsley Deprescribing Guidelines (Wiley-Blackwell; 2024). Dr. Horowitz is cofounder and consultant for Outro Health.
Incidence and risk factors of antidepressant withdrawal symptoms: a meta-analysis and systematic review - Molecular Psychiatry
Abstract Antidepressants are among the most extensively prescribed psychotropic drugs worldwide. Discontinuation induced withdrawal symptoms have been reported for almost all antidepressants. The incidence of antidepressant withdrawal syndrome (AWS) and other characteristics remain unknown. We searched the PubMed, Embase, PsycINFO, MEDLINE, CINAHL, and Cochrane Central Register of Controlled Trials databases from inception to December 31, 2023.
New study claims antidepressant withdrawal is less common than thought. But there’s a big problem
Welcome to NewsBreak, an open platform where diverse perspectives converge. Most of our content comes from established publications and journalists, as well as from our extensive network of tens of thousands of creators who contribute to our platform. We empower individuals to share insightful viewpoints through short posts and comments.
Study claiming antidepressant withdrawal is less common than thought fails to account for risks in long-term users
A new review of research about antidepressant withdrawal has confirmed it does exist, but also reports that it's less common and severe than previously found. These findings feed into a growing debate about how common and severe withdrawal effects are. But we argue the researchers probably underestimate the incidence in long-term users who are most at risk of withdrawal effects.
Study claiming antidepressant withdrawal is less common than thought fails to account for risks in long-term users
A new review of research about antidepressant withdrawal has confirmed it does exist, but also reports that it’s less common and severe than previously found. These findings feed into a growing debate about how common and severe withdrawal effects are. But we argue the researchers probably underestimate the incidence in long-term users who are most at risk of withdrawal effects.
Acceptability and optimisation of resources to support antidepressant cessation: a qualitative think-aloud study with patients in Australian primary care
antidepressive agent deprescriptions Introduction Around half of people who try to stop using antidepressants experience unpleasant withdrawal symptoms, which can last for weeks or months and sometimes longer.1,2 Withdrawal symptoms are more common and last longer than previously understood.
Short-term antidepressant efficacy is over-stated and long-term trends pose concerning questions
Dear Editor We thank Hardelid and colleagues for their response and would like to reply to their two central contentions. They cite the 2018 Cipriani meta-analysis as evidence for the effectiveness of antidepressants in moderate to severe depression.
No good argument for treating mild depression with antidepressants
Dear Editor We thank Jauhar and colleagues for their comments on our letter. Their overall point seems to be that the current scale of antidepressant use is not of concern, and that the use of antidepressants for mild conditions and those provoked by social and economic conditions is justified. We address their points in order.
Treaty notifications and MAP access: a small filing with a big impact
In the rush of year end, multinational entities (MNEs) are juggling competing priorities and deadlines. One deadline that can easily get missed relates to the requirement under certain US tax treaties to provide notification to the relevant competent authorities if the company may require competent authority assistance for prior tax years. If a required treaty notification is not filed, the taxpayer will not be able to benefit from competent authority assistance under the relevant treaty.
Acceptability and optimisation of resources to support antidepressant cessation: a qualitative think-aloud study with patients in Australian primary care
antidepressive agent deprescriptions INTRODUCTION Around half of people who try to stop using antidepressants experience unpleasant withdrawal symptoms, which can last for weeks or months and sometimes longer.1,2 Withdrawal symptoms are more common and last longer than previously understood.
Case-based learning: safe withdrawal and tapering of antidepressants
After reading this article, you should be able to: Understand the rationale for tapering antidepressants gradually, in a hyperbolic pattern and a rate titrated to the individual; Counsel a patient on how to undertake a careful, hyperbolic ; Help a patient use different formulations of medication to facilitate this process. It is now recognised that withdrawal effects from antidepressants are more common, and can be more severe and long-lasting than previously understood.
Behind declining standards in higher ed (opinion)
You have /5 articles left. Sign up for a free account or log in. Photo illustration by Justin Morrison/Inside Higher Ed “Americans Are Losing Faith in College Education,” proclaims The Wall Street Journal; “College Degrees Could Become Obsolete,” notes Forbes. These are just two in a flurry of headlines in recent years signaling the eroding legitimacy of the college degree.
Acceptability and optimisation of resources to support antidepressant cessation: A qualitative think-aloud study with patients
Abstract Background: Stopping long-term (>12 months) antidepressants can be difficult for patients because of unpleasant withdrawal symptoms. Many people do not recognise withdrawal symptoms or do not know how to minimise them to safely stop antidepressants. We developed the RELEASE resources to address these gaps: a medicines information brochure, a decision aid, and drug-specific hyperbolic tapering protocols.
Bachelor of Science
We and our partners use cookies✕ By using this site, you consent to the processing of your personal data, the storing of cookies on your device, and the use of similar technologies for personalization, ads, analytics, etc. For more information or to opt out, see our Privacy Policy
¿Y usted, de qué se ríe? De Kafka y Groucho Marx a Woody Allen: la historia del humor judío
De izquierda a derecha: Franz Kafka, Groucho Marx, Philip Roth, Jerry Lewis, Woody Allen, Mel Brooks y Larry David Letras Jeremy Dauber recorre más de 2.000 años para desentrañar las teorías que explican la evolución de la gracia judía en 'Una historia seria' 26 junio, 2023 02:01 ec-critica-letras ec-libro-semana Escritores Humor Humoristas ¿Los judíos siempre han sido divertidos?
Antidepressants can cause withdrawal symptoms-here's what you need to know
Millions of people worldwide take antidepressants to help with depression. But as a recent BBC Panorama found, many aren't aware of the fact that antidepressants can cause withdrawal symptoms when you stop taking them. For some, these symptoms can be severe and long-lasting. Here's what you should know. What causes antidepressant withdrawal? When we take psychotropic medications such as antidepressants, over time the brain and body adapt to the drug.
All smoke, no fire
Dear Editor Jauhar and colleagues have launched a ferocious attack on our review. They do not question the conclusion of our review that low serotonin does not cause depression,[1] but continue to claim that ‘changes in serotonin’ occur in depression.
Antidepressants can cause withdrawal symptoms - here’s what you need to know
Millions of people worldwide take antidepressants to help with depression. But as a recent BBC Panorama found, many aren’t aware of the fact that antidepressants can cause withdrawal symptoms when you stop taking them. For some, these symptoms can be severe and long-lasting. Here’s what you should know. What causes antidepressant withdrawal?
Antidepressants can cause withdrawal symptoms - here’s what you need to know Original
Millions of people worldwide take antidepressants to help with depression. But as a recent BBC Panorama found, many aren’t aware of the fact that antidepressants can cause withdrawal symptoms when you stop taking them. For some, these symptoms can be severe and long-lasting. Here’s what you should know. What causes antidepressant withdrawal? When we take psychotropic medications such as antidepressants, over time the brain and body adapt to the drug.
Fluoxetine Can Cause Epileptogenesis and Aberrant Neurogenesis in Male Wild Type Mice
Save citation to file Format: Add to My Bibliography Your saved search Name of saved search: Search terms: Frequency: Which day? Which day? Report format: Send at most: Send even when there aren't any new results Optional text in email: Create a file for external citation management software
Depresión de verano: qué es y por qué también el buen tiempo puede amargarnos
El buen tiempo o las vacaciones no tienen por qué suponer una alegría para ciertas personas que padecen un tipo de depresión estacional muy concreta Podría parecer un contrasentido que la depresión de verano también aparezca. Ese mood de tristeza, melancolía y apatía se vincula más al mal tiempo, al frío o a la oscuridad. Sin embargo, lo cierto es que hay depresiones estaciones incluso cuando el buen tiempo aparece.
Metabolites | Free Full-Text | Associations between Plasma Lipid Mediators and Chronic Daily Headache Outcomes in Patients Randomized to a Low Linoleic Acid Diet with or without Added Omega-3 Fatty Acids
This is an early access version, the complete PDF, HTML, and XML versions will be available soon. Open AccessArticle by Qing Shen 1, Jun Yang 2, Daisy Zamora 3,4,5, Mark Horowitz 3, Keturah R. Faurot 5, Beth A. MacIntosh 6, J. Douglas Mann 7, Bruce D. Hammock 2,8, Christopher E. Ramsden 3,5,9 and Ameer Y.
Step change in guidance on withdrawing antidepressants
Thank you for recommending British Journal of General Practice. NOTE: We only request your email address so that the person to whom you are recommending the page knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address. Your Email * Your Name * Send To * Enter multiple addresses on separate lines or separate them with commas.
Depression is probably not caused by a chemical imbalance
For three decades, people have been deluged with information suggesting that depression is caused by a “chemical imbalance” in the brain – namely an imbalance of a brain chemical called serotonin. However, our latest research review shows that the evidence does not support it.
Antidepressant withdrawal should be taken seriously-researchers investigating ways to help
Misinformation about antidepressants is rife and is probably fueling their rise in use. Chief among these false ideas are: Antidepressant withdrawal effects are mild and only last two to three weeks, with any severe symptoms interpreted as a relapse in depression. Antidepressants are not addictive, so they can't be that difficult to stop. If you are having difficulty getting off your antidepressant, that shows you must need them. You should be able to stop your antidepressants in a month or two.
Antidepressant withdrawal should be taken seriously – we're investigating ways to help people come off the pills Original
Misinformation about antidepressants is rife and is probably fuelling their rise in use. Chief among these false ideas are: Antidepressant withdrawal effects are mild and only last two to three weeks, with any severe symptoms interpreted as a relapse in depression. Antidepressants are not addictive, so they can’t be that difficult to stop. If you are having difficulty getting off your antidepressant, that shows you must need them. You should be able to stop your antidepressants in a month or two.
Six books from 2022 to add to your 2023 reading list
Best books of 2022 Discover all the OUP books from 2022 that topped critics' lists! By Ashendri Wickremasinghe January 9th 2023 With the new year unfolding before us and resolutions for the days ahead being made, it’s a good time to reflect on the pivotal moments and people that captured the attention of many in the last year. Here are six books from 2022 that reviewers and critics loved that you should add to your 2023 reading list: 1.
Why it is important to discuss what antidepressants do
News & Views Why it is important to...
Maintenance antipsychotic trials and the effect of withdrawal
Johannes Schneider-Thoma and colleagues 1 Schneider-Thoma J Chalkou K Dörries C et al. Comparative efficacy and tolerability of 32 oral and long-acting injectable antipsychotics for the maintenance treatment of adults with schizophrenia: a systematic review and network meta-analysis.
Chemical imbalance theory of depression: clearing up some misconceptions
The scale of the response to our recent study finding that there was no support for the idea that low serotonin causes depression – the so-called “chemical imbalance” theory of depression – was enormous. Our paper is one of the 400 most shared of the 21 million papers that have ever been tracked. And our article in The Conversation was read by more than 1.3 million people. However, we feel that some of the responses missed the point, and we’d like to address those points here.
Depression Is Probably Not Caused By A Chemical Imbalance In The Brain
pexels.com/@inzmamkhan11 For three decades, people have been deluged with information suggesting that depression is caused by a “chemical imbalance” in the brain – namely an imbalance of a brain chemical called serotonin. However, our latest research review shows that the evidence does not support it.
Chemical imbalance theory of depression: clearing up some misconceptions Original
The scale of the response to our recent study finding that there was no support for the idea that low serotonin causes depression – the so-called “chemical imbalance” theory of depression – was enormous. Our paper is one of the 400 most shared of the 21 million papers that have ever been tracked. And our article in The Conversation was read by more than 1.3 million people. However, we feel that some of the responses missed the point, and we’d like to address those points here.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Mark
Contact Mark, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack